2673189 Alberta Inc
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2026-2027
- Agreement period
- May 1, 2026 – March 31, 2027
- Reference
- nrc-cnrc:172-2026-2027-Q1-1041757
Published purpose
RNARevive intends to develop and validate a generative AI platform to improve the design of self-amplifying RNA therapeutics. The project will integrate proprietary and public sequence-outcome data to predict RNA stability, immunogenicity, and replication efficiency, and to prioritize the most promising candidates for experimental validation. The goal is to reduce construct attrition, shorten development timelines, and improve the success rate of RNA therapeutic programs.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 10, 2026 from open.canada.ca Grants & Contributions